Oxidative stress and autophagy in the regulation of lysosome-dependent neuron death

Antioxidants and Redox Signaling

Volumn 11, Issue 3, 2009, Pages 481-496

  Pivtoraiko, Violetta N ^a   Stone, Sara L ^a   Roth, Kevin A ^a   Shacka, John J ^a,b,c  

^a University of Alabama at Birmingham   (United States)

^b BIRMINGHAM VA MEDICAL CENTER   (United States)

^c SC 843A ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; CATHEPSIN D; CHLOROQUINE; FREE RADICAL; IRON; LIPOFUSCIN; REACTIVE OXYGEN METABOLITE;

AGING; ALZHEIMER DISEASE; AUTOPHAGY; CELL FUNCTION; CELL STRUCTURE; DEGENERATIVE DISEASE; HUMAN; LYSOSOME; LYSOSOME MEMBRANE; LYSOSOME STORAGE DISEASE; MEMBRANE PERMEABILITY; NERVE CELL NECROSIS; NEURONAL CEROID LIPOFUSCINOSIS; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; CELL DEATH; CYTOLOGY; METABOLISM; NERVE CELL; PHYSIOLOGY;

ALZHEIMER DISEASE; AUTOPHAGY; CELL DEATH; HUMANS; LYSOSOMES; NEURONS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 58849163098     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2008.2263     Document Type: Review

References (174)

1. Adam-Vizi V and Chinopoulos C. Bioenergetics and the formation of mitochondrial reactive oxygen species. Trends Pharmacol Sci 27: 639-645, 2006.
2. Adamec E, Mohan PS, Cataldo AM, Vonsattel JP, and Nixon RA. Up-regulation of the lysosomal system in experimental models of neuronal injury: implications for Alzheimer's disease. Neuroscience 100: 663-675, 2000.
3. Amano T, Nakanishi H, Kondo T, Tanaka T, Oka M, and Yamamoto K. Age-related changes in cellular localization and enzymatic activities of cathepsins B, L and D in the rat trigeminal ganglion neuron. Mech Ageing Dev 83: 133-141, 1995.
4. Ambroso JL and Harris C. Chloroquine accumulation and alterations of proteolysis and pinocytosis in the rat conceptus in vitro. Biochem Pharmacol 47: 679-688, 1994.
5. 2 is a consequence of lysosomal rupture. Biochem J 356: 549-555, 2001.
6. Awano T, Katz ML, O'Brien DP, Taylor JF, Evans J, Khan S, Sohar I, Lobel P, and Johnson GS. A mutation in the cathepsin D gene (CTSD) in American Bulldogs with neuronal ceroid lipofuscinosis. Mol Genet Metab 87: 341-348, 2006.
7. Baird SK, Kurz T, and Brunk UT. Metallothionein protects against oxidative stress-induced lysosomal destabilization. Biochem J 394: 275-283, 2006.
8. Behl C, Davis JB, Lesley R, and Schubert D. Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 77: 817-827, 1994.
9. Bendiske J and Bahr BA. Lysosomal activation is a compensatory response against protein accumulation and associated synaptopathogenesis: an approach for slowing Alzheimer disease? J Neuropathol Exp Neurol 62: 451-463, 2003.
10. Bernales S, Schuck S, and Walter P. ER-phagy: selective autophagy of the endoplasmic reticulum. Autophagy 3: 285-287, 2007.
11. Bhattacharyya B, Chatterjee TK, and Ghosh JJ. Effects of chloroquine on lysosomal enzymes, NADPH-induced lipid peroxidation, and antioxidant enzymes of rat retina. Biochem Pharmacol 32: 2965-2968, 1983.
12. Bidere N, Lorenzo HK, Carmona S, Laforge M, Harper F, Dumont C, and Senik A. Cathepsin D triggers Bax activation, resulting in selective apoptosis-inducing factor (AIF) relocation in T lymphocytes entering the early commitment phase to apoptosis. J Biol Chem 278: 31401-31411, 2003.
13. Bowman EJ, Siebers A, and Altendorf K. Bafilomycins: a class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells. Proc Natl Acad Sci U S A 85: 7972-7976, 1988.
14. Boya P, Gonzalez-Polo RA, Poncet D, Andreau K, Vieira HL, Roumier T, Perfettini JL, and Kroemer G. Mitochondrial membrane permeabilization is a critical step of lysosome-initiated apoptosis induced by hydroxychloroquine. Oncogene 22: 3927-3936, 2003.
15. Brun A and Brunk U. Histochemical indications for lysosomal localization of heavy metals in normal rat brain and liver. J Histochem Cytochem 18: 820-827, 1970.
16. Brunk UT, Jones CB, and Sohal RS. A novel hypothesis of lipofuscinogenesis and cellular aging based on interactions between oxidative stress and autophagocytosis. Mutat Res 275: 395-403, 1992.
17. Brunk UT and Terman A. Lipofuscin: mechanisms of age-related accumulation and influence on cell function. Free Radic Biol Med 33: 611-619, 2002.
18. Butler D, Brown QB, Chin DJ, Batey L, Karim S, Mutneja MS, Karanian DA, and Bahr BA. Cellular responses to protein accumulation involve autophagy and lysosomal enzyme activation. Rejuvenation Res 8: 227-237, 2005.
19. Canu N, Tufi R, Serafino AL, Amadoro G, Ciotti MT, and Calissano P. Role of the autophagic-lysosomal system on low potassium-induced apoptosis in cultured cerebellar granule cells. J Neurochem 92: 1228-1242, 2005.
20. Castellani RJ, Honda K, Zhu X, Cash AD, Nunomura A, Perry G, and Smith MA. Contribution of redox-active iron and copper to oxidative damage in Alzheimer disease. Ageing Res Rev 3: 319-326, 2004.
21. Castino R, Bellio N, Nicotra G, Follo C, Trincheri NF, and Isidoro C. Cathepsin D-Bax death pathway in oxidative stressed neuroblastoma cells. Free Radic Biol Med 42: 1305-1316, 2007.
22. Cataldo AM, Barnett JL, Berman SA, Li J, Quarless S, Bursztajn S, Lippa C, and Nixon RA. Gene expression and cellular content of cathepsin D in Alzheimer's disease brain: evidence for early up-regulation of the endosomal-lysosomal system. Neuron 14: 671-680, 1995.
23. Cataldo AM, Barnett JL, Pieroni C, and Nixon RA. Increased neuronal endocytosis and protease delivery to early endosomes in sporadic Alzheimer's disease: neuropathologic evidence for a mechanism of increased beta-amyloidogenesis. J Neurosci 17: 6142-6151, 1997.
24. Cataldo AM, Hamilton DJ, Barnett JL, Paskevich PA, and Nixon RA. Properties of the endosomal-lysosomal system in the human central nervous system: disturbances mark most neurons in populations at risk to degenerate in Alzheimer's disease. J Neurosci 16: 186-199, 1996.
25. Cataldo AM, Hamilton DJ, and Nixon RA. Lysosomal abnormalities in degenerating neurons link neuronal compromise to senile plaque development in Alzheimer disease. Brain Res 640: 68-80, 1994.
26. Cataldo AM and Nixon RA. Enzymatically active lysosomal proteases are associated with amyloid deposits in Alzheimer brain. Proc Natl Acad Sci U S A 87: 3861-3865, 1990.
27. Cataldo AM, Paskevich PA, Kominami E, and Nixon RA. Lysosomal hydrolases of different classes are abnormally distributed in brains of patients with Alzheimer disease. Proc Natl Acad Sci U S A 88: 10998-11002, 1991.
28. Cataldo AM, Peterhoff CM, Troncoso JC, Gomez-Isla T, Hyman BT, and Nixon RA. Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations. Am J Pathol 157: 277-286, 2000.
29. Cataldo AM, Thayer CY, Bird ED, Wheelock TR, and Nixon RA. Lysosomal proteinase antigens are prominently localized within senile plaques of Alzheimer's disease: evidence for a neuronal origin. Brain Res 513: 181-192, 1990.
30. Chen JJ, Bertrand H, and Yu BP. Inhibition of adenine nucleotide translocator by lipid peroxidation products. Free Radic Biol Med 19: 583-590, 1995.
31. Chevallier N, Vizzavona J, Marambaud P, Baur CP, Spillantini M, Fulcrand P, Martinez J, Goedert M, Vincent JP, and Checler F. Cathepsin D displays in vitro beta-secretase-like specificity. Brain Res 750: 11-19, 1997.
32. Chimienti F, Jourdan E, Favier A, and Seve M. Zinc resistance impairs sensitivity to oxidative stress in HeLa cells: protection through metallothioneins expression. Free Radic Biol Med 31: 1179-1190, 2001.
33. Choi JH, Kim DH, Yun IJ, Chang JH, Chun BG, and Choi SH. Zaprinast inhibits hydrogen peroxide-induced lysosomal destabilization and cell death in astrocytes. Eur J Pharmacol 571: 106-115, 2007.
34. Chu T, Tran T, Yang F, Beech W, Cole GM, and Frautschy SA. Effect of chloroquine and leupeptin on intracellular accumulation of amyloid-beta (A beta) 1-42 peptide in a murine N9 microglial cell line. FEBS Lett 436: 439-444, 1998.
35. Cirman T, Oresic K, Mazovec GD, Turk V, Reed JC, Myers RM, Salvesen GS, and Turk B. Selective disruption of lysosomes in HeLa cells triggers apoptosis mediated by cleavage of Bid by multiple papain-like lysosomal cathepsins. J Biol Chem 279: 3578-3587, 2004.
36. Cohn JA, Tsai L, Friguet B, and Szweda LI. Chemical characterization of a protein-4-hydroxy-2-nonenal cross-link: immunochemical detection in mitochondria exposed to oxidative stress. Arch Biochem Biophys 328: 158-164, 1996.
37. Collins VP, Arborgh B, Brunk U, and Schellens JP. Phagocytosis and degradation of rat liver mitochondria by cultivated human glial cells. Lab Invest 42: 209-216, 1980.
38. Dare E, Li W, Zhivotovsky B, Yuan X, and Ceccatelli S. Methylmercury and H(2)O(2) provoke lysosomal damage in human astrocytoma D384 cells followed by apoptosis. Free Radic Biol Med 30: 1347-1356, 2001.
39. Daugas E, Susin SA, Zamzami N, Ferri KF, Irinopoulou T, Larochette N, Prevost MC, Leber B, Andrews D, Penninger J, and Kroemer G. Mitochondrio-nuclear translocation of AIF in apoptosis and necrosis. FASEB J 14: 729-739, 2000.
40. de Duve C. Lysosomes revisited. Eur J Biochem 137: 391-397, 1983.
41. de Duve C. The lysosome turns fifty. Nat Cell Biol 7: 847-849, 2005.
42. de Duve C, de Barsy T, Poole B, Trouet A, Tulkens P, and Van Hoof F. Commentary: kysosomotropic agents. Biochem Pharmacol 23: 2495-2531, 1974.
43. Decker RS, Decker ML, Thomas V, and Fuseler JW. Responses of cultured cardiac myocytes to lysosomotropic compounds and methylated amino acids. J Cell Sci 74: 119-135, 1985.
44. Deshpande A, Mina E, Glabe C, and Busciglio J. Different conformations of amyloid beta induce neurotoxicity by distinct mechanisms in human cortical neurons. J Neurosci 26: 6011-6018, 2006.
45. Dice JF. Chaperone-mediated autophagy. Autophagy 3: 295-299, 2007.
46. Ditaranto K, Tekirian TL, and Yang AJ. Lysosomal membrane damage in soluble Abeta-mediated cell death in Alzheimer's disease. Neurobiol Dis 8: 19-31, 2001.
47. Elleder M, Sokolova J, and Hrebicek M. Follow-up study of subunit c of mitochondrial ATP synthase (SCMAS) in Batten disease and in unrelated lysosomal disorders. Acta Neuropathol 93: 379-390, 1997.
48. Elojeimy S, Holman DH, Liu X, El Zawahry A, Villani M, Cheng JC, Mahdy A, Zeidan Y, Bielwaska A, Hannun YA and Norris JS. New insights on the use of desipramine as an inhibitor for acid ceramidase. FEBS Lett 580: 4751-4756, 2006.
49. Eskelinen EL, Tanaka Y, and Saftig P. At the acidic edge: emerging functions for lysosomal membrane proteins. Trends Cell Biol 13: 137-145, 2003.
50. Esterbauer H, Schaur RJ, and Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 11: 81-128, 1991.
51. Fitch CD. Ferriprotoporphyrin IX, phospholipids, and the antimalarial actions of quinoline drugs. Life Sci 74: 1957-1972, 2004.
52. Floyd RA and Hensley K. Oxidative stress in brain aging: implications for therapeutics of neurodegenerative diseases. Neurobiol Aging 23: 795-807, 2002.
53. Fong D and Bonner JT. Proteases in cellular slime mold development: evidence for their involvement. Proc Natl Acad Sci U S A 76: 6481-6485, 1979.
54. Friguet B, Stadtman ER, and Szweda LI. Modification of glucose-6-phosphate dehydrogenase by 4-hydroxy-2-nonenal: formation of cross-linked protein that inhibits the multicatalytic protease. J Biol Chem 269: 21639-21643, 1994.
55. Friguet B, Szweda LI, and Stadtman ER. Susceptibility of glucose-6-phosphate dehydrogenase modified by 4-hydroxy-2-nonenal and metal-catalyzed oxidation to proteolysis by the multicatalytic protease. Arch Biochem Biophys 311: 168-173, 1994.
56. Goebel HH and Wisniewski KE. Current state of clinical and morphological features in human NCL. Brain Pathol 14: 61-69, 2004.
57. Golstein P and Kroemer G. Redundant cell death mechanisms as relics and backups. Cell Death Differ 12(suppl 2): 1490-1496, 2005.
58. Gonzalez-Noriega A, Grubb JH, Talkad V, and Sly WS. Chloroquine inhibits lysosomal enzyme pinocytosis and enhances lysosomal enzyme secretion by impairing receptor recycling. J Cell Biol 85: 839-852, 1980.
59. Gordon PB and Seglen PO. Prelysosomal convergence of autophagic and endocytic pathways. Biochem Biophys Res Commun 151: 40-47, 1988.
60. Guicciardi ME, Deussing J, Miyoshi H, Bronk SF, Svingen PA, Peters C, Kaufmann SH, and Gores GJ. Cathepsin B contributes to TNF-alpha-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c. J Clin Invest 106: 1127-1137, 2000.
61. Guicciardi ME, Leist M, and Gores GJ. Lysosomes in cell death. Oncogene 23: 2881-2890, 2004.
62. Hamano T, Gendron TF, Causevic E, Yen SH, Lin WL, Isidoro C, Deture M, and Ko LW. Autophagic-lysosomal perturbation enhances tau aggregation in transfectants with induced wild-type tau expression. Eur J Neurosci 27: 1119-1130, 2008.
63. Harman D. Lipofuscin and ceroid formation: the cellular recycling system. Adv Exp Med Biol 266: 3-15, 1989.
64. Heinrich M, Neumeyer J, Jakob M, Hallas C, Tchikov V, Winoto-Morbach S, Wickel M, Schneider-Brachert W, Trauzold A, Hethke A, and Schutze S. Cathepsin D links TNF-induced acid sphingomyelinase to Bid-mediated caspase-9 and -3 activation. Cell Death Differ 11: 550-563, 2004.
65. Hoppe G, O'Neil J, and Hoff HF. Inactivation of lysosomal proteases by oxidized low density lipoprotein is partially responsible for its poor degradation by mouse peritoneal macrophages. J Clin Invest 94: 1506-1512, 1994.
66. Huang X, Atwood CS, Hartshorn MA, Multhaup G, Goldstein LE, Scarpa RC, Cuajungco MP, Gray DN, Lim J, Moir RD, Tanzi RE, and Bush AI. The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry 38: 7609-7616, 1999.
67. Hwang JJ, Lee SJ, Kim TY, Cho JH, and Koh JY. Zinc and 4-hydroxy-2-nonenal mediate lysosomal membrane permeabilization induced by H2O2 in cultured hippocampal neurons. J Neurosci 28: 3114-3122, 2008.
68. Ivanina TA, Sakina NL, Lebedeva MN, and Borovyagin VL. A study of the mechanisms of chloroquine retinopathy, I: chloroquine effect on lipid peroxidation of retina. Ophthalmic Res 21: 216-220, 1989.
69. Ivy GO, Kanai S, Ohta M, Smith G, Sato Y, Kobayashi M, and Kitani K. Lipofuscin-like substances accumulate rapidly in brain, retina and internal organs with cysteine protease inhibition. Adv Exp Med Biol 266: 31-45, 1989.
70. Ivy GO, Schottler F, Wenzel J, Baudry M, and Lynch G. Inhibitors of lysosomal enzymes: accumulation of lipofuscinlike dense bodies in the brain. Science 226: 985-987, 1984.
71. Jaattela M, Benedict M, Tewari M, Shayman JA, and Dixit VM. Bcl-x and Bcl-2 inhibit TNF and Fas-induced apoptosis and activation of phospholipase A2 in breast carcinoma cells. Oncogene 10: 2297-2305, 1995.
72. Jaffrezou JP, Chen G, Duran GE, Muller C, Bordier C, Laurent G, Sikic BI, and Levade T. Inhibition of lysosomal acid sphingomyelinase by agents which reverse multidrug resistance. Biochim Biophys Acta 1266: 1-8, 1995.
73. Kagedal K, Johansson U, and Ollinger K. The lysosomal protease cathepsin D mediates apoptosis induced by oxidative stress. FASEB J 15: 1592-1594, 2001.
74. Kagedal K, Zhao M, Svensson I, and Brunk UT. Sphingosine-induced apoptosis is dependent on lysosomal proteases. Biochem J 359: 335-343, 2001.
75. Kidane TZ, Sauble E, and Linder MC. Release of iron from ferritin requires lysosomal activity. Am J Physiol Cell Physiol 291: C445-C455, 2006.
76. Kim I, Rodriguez-Enriquez S, and Lemasters JJ. Selective degradation of mitochondria by mitophagy. Arch Biochem Biophys 462: 245-253, 2007.
77. Klionsky DJ, Cuervo AM, Dunn WA Jr, Levine B, van dK I, and Seglen PO. How shall I eat thee? Autophagy 3: 413-416, 2007.
78. Koike M, Nakanishi H, Saftig P, Ezaki J, Isahara K, Ohsawa Y, Schulz-Schaeffer W, Watanabe T, Waguri S, Kametaka S, Shibata M, Yamamoto K, Kominami E, Peters C, von Figura K, and Uchiyama Y. Cathepsin D deficiency induces lysosomal storage with ceroid lipofuscin in mouse CNS neurons. J Neurosci 20: 6898-6906, 2000.
79. Koike M, Shibata M, Waguri S, Yoshimura K, Tanida I, Kominami E, Gotow T, Peters C, von Figura K, Mizushima N, Saftig P, and Uchiyama Y. Participation of autophagy in storage of lysosomes in neurons from mouse models of neuronal ceroid-lipofuscinoses (Batten disease). Am J Pathol 167: 1713-1728, 2005.
80. Kurz T, Gustafsson B, and Brunk UT. Intralysosomal iron chelation protects against oxidative stress-induced cellular damage. FEBS J 273: 3106-3117, 2006.
81. Kurz T, Terman A, and Brunk UT. Autophagy, ageing and apoptosis: the role of oxidative stress and lysosomal iron. Arch Biochem Biophys 462: 220-230, 2007.
82. Kwok JC and Richardson DR. Examination of the mechanism(s) involved in doxorubicin-mediated iron accumulation in ferritin: studies using metabolic inhibitors, protein synthesis inhibitors, and lysosomotropic agents. Mol Pharmacol 65: 181-195, 2004.
83. Li H, Zhu H, Xu CJ, and Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94: 491-501, 1998.
84. Li W, Yuan X, Nordgren G, Dalen H, Dubowchik GM, Firestone RA, and Brunk UT. Induction of cell death by the lysosomotropic detergent MSDH. FEBS Lett 470: 35-39, 2000.
85. Liou W, Geuze HJ, Geelen MJ, and Slot JW. The autophagic and endocytic pathways converge at the nascent autophagic vacuoles. J Cell Biol 136: 61-70, 1997.
86. Luzio JP, Pryor PR, Gray SR, Gratian MJ, Piper RC, and Bright NA. Membrane traffic to and from lysosomes. Biochem Soc Symp 72: 77-86, 2005.
87. Lynch G and Bi X. Lysosomes and brain aging in mammals. Neurochem Res 28: 1725-1734, 2003.
88. Marquardt T, Braulke T, Hasilik A, and von Figura K. Association of the precursor of cathepsin D with coated membranes: kinetics and carbohydrate processing. Eur J Biochem 168: 37-42, 1987.
89. Michihara A, Toda K, Kubo T, Fujiwara Y, Akasaki K, and Tsuji H. Disruptive effect of chloroquine on lysosomes in cultured rat hepatocytes. Biol Pharm Bull 28: 947-951, 2005.
90. Mielke JG, Murphy MP, Maritz J, Bengualid KM, and Ivy GO. Chloroquine administration in mice increases beta-amyloid immunoreactivity and attenuates kainate-induced blood-brain barrier dysfunction. Neurosci Lett 227: 169-172, 1997.
91. Mole SE. The genetic spectrum of human neuronal ceroid-lipofuscinoses. Brain Pathol 14: 70-76, 2004.
92. Moreira PI, Santos MS, Oliveira CR, Shenk JC, Nunomura A, Smith MA, Zhu X, and Perry G. Alzheimer disease and the role of free radicals in the pathogenesis of the disease. CNS Neurol Disord Drug Targets 7: 3-10, 2008.
93. Moreira PI, Siedlak SL, Wang X, Santos MS, Oliveira CR, Tabaton M, Nunomura A, Szweda LI, Aliev G, Smith MA, Zhu X, and Perry G. Autophagocytosis of mitochondria is prominent in Alzheimer disease. J Neuropathol Exp Neurol 66: 525-532, 2007.
94. Mueller-Steiner S, Zhou Y, Arai H, Roberson ED, Sun B, Chen J, Wang X, Yu G, Esposito L, Mucke L, and Gan L. Antiamyloidogenic and neuroprotective functions of cathepsin B: implications for Alzheimer's disease. Neuron 51: 703-714, 2006.
95. Nakanishi H, Zhang J, Koike M, Nishioku T, Okamoto Y, Kominami E, von Figura K, Peters C, Yamamoto K, Saftig P and Uchiyama Y. Involvement of nitric oxide released from microglia-macrophages in pathological changes of cathepsin D-deficient mice. J Neurosci 21: 7526-7533, 2001.
96. Neufeld EF. Lysosomal storage diseases. Annu Rev Biochem 60: 257-280, 1991.
97. Ngaha EO and Akanji MA. Effect of chloroquine on the stability of rat kidney lysosomes in vivo and in vitro. Comp Biochem Physiol C 73: 109-113, 1982.
98. Nilsson C, Johansson U, Johansson AC, Kagedal K, and Ollinger K. Cytosolic acidification and lysosomal alkalinization during TNF-alpha induced apoptosis in U937 cells. Apoptosis 11: 1149-1159, 2006.
99. Nilsson C, Kagedal K, Johansson U, and Ollinger K. Analysis of cytosolic and lysosomal pH in apoptotic cells by flow cytometry. Methods Cell Sci 25: 185-194, 2003.
100. Nishimura Y, Amano J, Sato H, Tsuji H, and Kato K. Biosynthesis of lysosomal cathepsins B and H in cultured rat hepatocytes. Arch Biochem Biophys 262: 159-170, 1988.
101. Nishimura Y, Kato K, Furuno K, and Himeno M. Biosynthesis and processing of lysosomal cathepsin D in primary cultures of rat hepatocytes. Biol Pharm Bull 18: 825-828, 1995.
102. Nixon RA. A "protease activation cascade" in the pathogenesis of Alzheimer's disease. Ann N Y Acad Sci 924: 117-131, 2000.
103. Nixon RA. Autophagy, amyloidogenesis and Alzheimer disease. J Cell Sci 120: 4081-4091, 2007.
104. Nixon RA, Wegiel J, Kumar A, Yu WH, Peterhoff C, Cataldo A, and Cuervo AM. Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study. J Neuropathol Exp Neurol 64: 113-122, 2005.
105. Nixon RA, Yang DS, and Lee JH. Neurodegenerative lysosomal disorders: a continuum from development to late age. Autophagy 4: 590-599, 2008.
106. Ohkuma S and Poole B. Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents. Proc Natl Acad Sci U S A 75: 3327-3331, 1978.
107. Ohkuma S and Poole B. Cytoplasmic vacuolation of mouse peritoneal macrophages and the uptake into lysosomes of weakly basic substances. J Cell Biol 90: 656-664, 1981.
108. Okouchi M, Ekshyyan O, Maracine M, and Aw TY. Neuronal apoptosis in neurodegeneration. Antioxid Redox Signal 9: 1059-1096, 2007.
109. Ollinger K and Brunk UT. Cellular injury induced by oxidative stress is mediated through lysosomal damage. Free Radic Biol Med 19: 565-574, 1995.
110. Park BC, Park SH, Paek SH, Park SY, Kwak MK, Choi HG, Yong CS, Yoo BK, and Kim JA. Chloroquine-induced nitric oxide increase and cell death is dependent on cellular GSH depletion in A172 human glioblastoma cells. Toxicol Lett 178: 52-60, 2008.
111. Radisky DC and Kaplan J. Iron in cytosolic ferritin can be recycled through lysosomal degradation in human fibroblasts. Biochem J 336: 201-205, 1998.
112. Raley MJ, Schwacha MG, and Loegering DJ. Lysosomotropic agents ameliorate macrophage dysfunction following the phagocytosis of IgG-coated erythrocytes: a role for lipid peroxidation. Inflammation 21: 619-628, 1997.
113. Rauch-Lüllmann Renate. History and morphology of the lysosome. In: Lysosomes, edited by Saftig P. New York: Springer Science Business Media; Landes Bioscience, 2005, pp. 1-16.
114. Roberg K, Kagedal K, and Ollinger K. Microinjection of cathepsin d induces caspase-dependent apoptosis in fibroblasts. Am J Pathol 161: 89-96, 2002.
115. Roberts S and Bomford A. Ferritin iron kinetics and protein turnover in K562 cells. J Biol Chem 263: 19181-19187, 1988.
116. Roth KA. Caspases, apoptosis, and Alzheimer disease: causation, correlation, and confusion. J Neuropathol Exp Neurol 60: 829-838, 2001.
117. Saftig P. Lysosomal Membrane Proteins. In: Lysosomes, edited by Saftig P. New York: Springer Science Business Media, 2005, pp. 37-49.
118. Saftig P, Hetman M, Schmahl W, Weber K, Heine L, Mossmann H, Koster A, Hess B, Evers M, von Figura K, and Peters C. Mice deficient for the lysosomal proteinase cathepsin D exhibit progressive atrophy of the intestinal mucosa and profound destruction of lymphoid cells. EMBO J 14: 3599-3608, 1995.
119. Saftig P, Peters C, von Figura K, Craessaerts K, Van Leuven F, and De Strooper B. Amyloidogenic processing of human amyloid precursor protein in hippocampal neurons devoid of cathepsin D. J Biol Chem 271: 27241-27244, 1996.
120. Sakai M, Araki N, and Ogawa K. Lysosomal movements during heterophagy and autophagy: with special reference to nematolysosome and wrapping lysosome. J Electron Microsc Tech 12: 101-131, 1989.
121. Sakaida I, Kyle ME, and Farber JL. Autophagic degradation of protein generates a pool of ferric iron required for the killing of cultured hepatocytes by an oxidative stress. Mol Pharmacol 37: 435-442, 1990.
122. Samarel AM, Ferguson AG, Decker RS, and Lesch M. Effects of cysteine protease inhibitors on rabbit cathepsin D maturation. Am J Physiol 257: C1069-C1079, 1989.
123. Sanvicens N and Cotter TG. Ceramide is the key mediator of oxidative stress-induced apoptosis in retinal photoreceptor cells. J Neurochem 98: 1432-1444, 2006.
124. Scherz-Shouval R, Shvets E, Fass E, Shorer H, Gil L, and Elazar Z. Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4. EMBO J 26: 1749-1760, 2007.
125. Schipper HM. Brain iron deposition and the free radical-mitochondrial theory of ageing. Ageing Res Rev 3: 265-301, 2004.
126. Seglen PO and Gordon PB. Effects of lysosomotropic monoamines, diamines, amino alcohols, and other amino compounds on protein degradation and protein synthesis in isolated rat hepatocytes. Mol Pharmacol 18: 468-475, 1980.
127. Selznick LA, Zheng TS, Flavell RA, Rakic P, and Roth KA. Amyloid beta-induced neuronal death is bax-dependent but caspase-independent. J Neuropathol Exp Neurol 59: 271-279, 2000.
128. Shacka JJ, Klocke BJ, and Roth KA. Autophagy, bafilomycin and cell death: the "a-B-cs" of plecomacrolide-induced neuroprotection. Autophagy 2: 228-230, 2006.
129. Shacka JJ, Klocke BJ, Shibata M, Uchiyama Y, Datta G, Schmidt RE, and Roth KA. Bafilomycin A1 inhibits chloroquine-induced death of cerebellar granule neurons. Mol Pharmacol 69: 1125-1136, 2006.
130. Shacka JJ, Klocke BJ, Young C, Shibata M, Olney JW, Uchiyama Y, Saftig P, and Roth KA. Cathepsin D deficiency induces persistent neurodegeneration in the absence of Bax-dependent apoptosis. J Neurosci 27: 2081-2090, 2007.
131. Shacka JJ, Roth KA, and Zhang J. The autophagy-lysosomal degradation pathway: role in neurodegenerative disease and therapy. Front Biosci 13: 718-736, 2008.
132. Shacka JJ, Sahawneh MA, Gonzalez JD, Ye YZ, D'Alessandro TL, and Estevez AG. Two distinct signaling pathways regulate peroxynitrite-induced apoptosis in PC12 cells. Cell Death Differ 13: 1506-1514, 2006.
133. Shamsi FA and Boulton M. Inhibition of RPE lysosomal and antioxidant activity by the age pigment lipofuscin. Invest Ophthalmol Vis Sci 42: 3041-3046, 2001.
134. Siems WG, Hapner SJ, and van Kuijk FJ. 4-Hydroxynonenal inhibits Na(+)-K(+)-ATPase. Free Radic Biol Med 20: 215-223, 1996.
135. Siintola E, Partanen S, Stromme P, Haapanen A, Haltia M, Maehlen J, Lehesjoki AE, and Tyynela J. Cathepsin D deficiency underlies congenital human neuronal ceroid-lipofuscinosis. Brain 129: 1438-1445, 2006.
136. Sohal RS, Arnold LA, and Sohal BH. Age-related changes in antioxidant enzymes and prooxidant generation in tissues of the rat with special reference to parameters in two insect species. Free Radic Biol Med 9: 495-500, 1990.
137. Sohal RS, Marzabadi MR, Galaris D, and Brunk UT. Effect of ambient oxygen concentration on lipofuscin accumulation in cultured rat heart myocytes: a novel in vitro model of lipofuscinogenesis. Free Radic Biol Med 6: 23-30, 1989.
138. Solheim AE and Seglen PO. Structural and physical changes in lysosomes from isolated rat hepatocytes treated with methylamine. Biochim Biophys Acta 763: 284-291, 1983.
139. Starke PE, Gilbertson JD, and Farber JL. Lysosomal origin of the ferric iron required for cell killing by hydrogen peroxide. Biochem Biophys Res Commun 133: 371-379, 1985.
140. Steinfeld R, Reinhardt K, Schreiber K, Hillebrand M, Kraetzner R, Bruck W, Saftig P, and Gartner J. Cathepsin D deficiency is associated with a human neurodegenerative disorder. Am J Hum Genet 78: 988-998, 2006.
141. Stoka V, Turk B, Schendel SL, Kim TH, Cirman T, Snipas SJ, Ellerby LM, Bredesen D, Freeze H, Abrahamson M, Bromme D, Krajewski S, Reed JC, Yin XM, Turk V, and Salvesen GS. Lysosomal protease pathways to apoptosis: cleavage of bid, not pro-caspases, is the most likely route. J Biol Chem 276: 3149-3157, 2001.
142. Storch S and Braulke T. Transport of lysosomal enzymes. In Lysosomes, edited by Saftig P. New York: Springer Science+Business Media; Landes Bioscience, 2005, pp. 17-26.
143. Sugioka Y, Suzuki M, Sugioka K, and Nakano M. A ferriprotoporphyrin IX-chloroquine complex promotes membrane phospholipid peroxidation: a possible mechanism for antimalarial action. FEBS Lett 223: 251-254, 1987.
144. Szweda LI, Uchida K, Tsai L, and Stadtman ER. Inactivation of glucose-6-phosphate dehydrogenase by 4-hydroxy-2-nonenal: selective modification of an active-site lysine. J Biol Chem 268: 3342-3347, 1993.
145. Tamagno E, Parola M, Guglielmotto M, Santoro G, Bardini P, Marra L, Tabaton M, and Danni O. Multiple signaling events in amyloid beta-induced, oxidative stress-dependent neuronal apoptosis. Free Radic Biol Med 35: 45-58, 2003.
146. Tasdemir E, Maiuri MC, Tajeddine N, Vitale I, Criollo A, Vicencio JM, Hickman JA, Geneste O, and Kroemer G. Cell cycle-dependent induction of autophagy, mitophagy and reticulophagy. Cell Cycle 6: 2263-2267, 2007.
147. Terman A, Abrahamsson N, and Brunk UT. Ceroid/lipofuscin-loaded human fibroblasts show increased susceptibility to oxidative stress. Exp Gerontol 34: 755-770, 1999.
148. Terman A and Brunk UT. Ceroid/lipofuscin formation in cultured human fibroblasts: the role of oxidative stress and lysosomal proteolysis. Mech Ageing Dev 104: 277-291, 1998.
149. Terman A and Brunk UT. Lipofuscin: mechanisms of formation and increase with age. APMIS 106: 265-276, 1998.
150. Terman A, Gustafsson B, and Brunk UT. The lysosomal-mitochondrial axis theory of postmitotic aging and cell death. Chem Biol Interact 163: 29-37, 2006.
151. Thaw HH, Collins VP, and Brunk UT. Influence of oxygen tension, pro-oxidants and antioxidants on the formation of lipid peroxidation products (lipofuscin) in individual cultivated human glial cells. Mech Ageing Dev 24: 211-223, 1984.
152. Tsai L, Szweda PA, Vinogradova O, and Szweda LI. Structural characterization and immunochemical detection of a fluorophore derived from 4-hydroxy-2-nonenal and lysine. Proc Natl Acad Sci U S A 95: 7975-7980, 1998.
153. Tsuchiya K, Kohda Y, Yoshida M, Zhao L, Ueno T, Yamashita J, Yoshioka T, Kominami E, and Yamashima T. Postictal blockade of ischemic hippocampal neuronal death in primates using selective cathepsin inhibitors. Exp Neurol 155: 187-194, 1999.
154. Turk B, Dolenc I, Turk V, and Bieth JG. Kinetics of the pH-induced inactivation of human cathepsin L. Biochemistry 32: 375-380, 1993.
155. Tyynela J, Sohar I, Sleat DE, Gin RM, Donnelly RJ, Baumann M, Haltia M, and Lobel P. A mutation in the ovine cathepsin D gene causes a congenital lysosomal storage disease with profound neurodegeneration. EMBO J 19: 2786-2792, 2000.
156. Uchida K and Stadtman ER. Covalent attachment of 4-hydroxynonenal to glyceraldehyde-3-phosphate dehydrogenase: a possible involvement of intra- and intermolecular cross-linking reaction. J Biol Chem 268: 6388-6393, 1993.
157. Uchiyama Y. Autophagic cell death and its execution by lysosomal cathepsins. Arch Histol Cytol 64: 233-246, 2001.
158. Uttenweiler A and Mayer A. Microautophagy in the yeast Saccharomyces cerevisiae. Methods Mol Biol 445: 245-259, 2008.
159. Von Zglinicki T, Nilsson E, Docke WD, and Brunk UT. Lipofuscin accumulation and ageing of fibroblasts. Gerontology 41(suppl 2): 95-108, 1995.
160. Walls KC, Klocke BJ, Saftig P, Shibata M, Uchiyama Y, Roth KA, and Shacka JJ. Altered regulation of phosphatidylinositol 3-kinase signaling in cathepsin D-deficient brain. Autophagy 3: 222-229, 2007.
161. Wang JH, Redmond HP, Watson RW, and Bouchier-Hayes D. Induction of human endothelial cell apoptosis requires both heat shock and oxidative stress responses. Am J Physiol 272: C1543-C1551, 1997.
162. Werneburg NW, Guicciardi ME, Bronk SF, Kaufmann SH, and Gores GJ. Tumor necrosis factor-related apoptosis-inducing ligand activates a lysosomal pathway of apoptosis that is regulated by Bcl-2 proteins. J Biol Chem 282: 28960-28970, 2007.
163. Wibo M and Poole B. Protein degradation in cultured cells. II. The uptake of chloroquine by rat fibroblasts and the inhibition of cellular protein degradation and cathepsin B1. J Cell Biol 63: 430-440, 1974.
164. Yamasaki R, Zhang J, Koshiishi I, Sastradipura Suniarti DF, Wu Z, Peters C, Schwake M, Uchiyama Y, Kira J, Saftig P, Utsumi H, and Nakanishi H. Involvement of lysosomal storage-induced p38 MAP kinase activation in the overproduction of nitric oxide by microglia in cathepsin D-deficient mice. Mol Cell Neurosci 35: 573-584, 2007.
165. Yap YW, Whiteman M, Bay BH, Li Y, Sheu FS, Qi RZ, Tan CH, and Cheung NS. Hypochlorous acid induces apoptosis of cultured cortical neurons through activation of calpains and rupture of lysosomes. J Neurochem 98: 1597-1609, 2006.
166. Yu WH, Cuervo AM, Kumar A, Peterhoff CM, Schmidt SD, Lee JH, Mohan PS, Mercken M, Farmery MR, Tjernberg LO, Jiang Y, Duff K, Uchiyama Y, Naslund J, Mathews PM, Cataldo AM, and Nixon RA. Macroautophagy: a novel beta-amyloid peptide-generating pathway activated in Alzheimer's disease. J Cell Biol 171: 87-98, 2005.
167. Yu Z, Persson HL, Eaton JW, and Brunk UT. Intralysosomal iron: a major determinant of oxidant-induced cell death. Free Radic Biol Med 34: 1243-1252, 2003.
168. Zaidi AU, McDonough JS, Klocke BJ, Latham CB, Korsmeyer SJ, Flavell RA, Schmidt RE, and Roth KA. Chloroquine-induced neuronal cell death is p53 and Bcl-2 family-dependent but caspase-independent. J Neuropathol Exp Neurol 60: 937-945, 2001.
169. Zecca L, Youdim MB, Riederer P, Connor JR, and Crichton RR. Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci 5: 863-873, 2004.
170. Zhao H, Cai Y, Santi S, Lafrenie R, and Lee H. Chloroquine-mediated radiosensitization is due to the destabilization of the lysosomal membrane and subsequent induction of cell death by necrosis. Radiat Res 164: 250-257, 2005.
171. Zhao M, Antunes F, Eaton JW, and Brunk UT. Lysosomal enzymes promote mitochondrial oxidant production, cytochrome c release and apoptosis. Eur J Biochem 270: 3778-3786, 2003.
172. Zhao M, Brunk UT, and Eaton JW. Delayed oxidant-induced cell death involves activation of phospholipase A2. FEBS Lett 509: 399-404, 2001.
173. Zhao M, Eaton JW, and Brunk UT. Bcl-2 phosphorylation is required for inhibition of oxidative stress-induced lysosomal leak and ensuing apoptosis. FEBS Lett 509: 405-412, 2001.
174. Zheng L, Roberg K, Jerhammar F, Marcusson J, and Terman A. Autophagy of amyloid beta-protein in differentiated neuroblastoma cells exposed to oxidative stress. Neurosci Lett 394: 184-189, 2006.